German industry keeps close eye on undue pressure on suppliers:
This article was originally published in Clinica
Customers seeking discounts from suppliers - in whatever industry sector - is common business practice. German medtech industry association Spectaris notes, however, that pressure from clinics on suppliers to alter price schedules to suit a single - albeit economically important - customer (or group of customers acting as a cartel) effectively contravenes the law on unfair competition (UWG). This is the case if the supplier is constrained by the action of a hospital or clinic in such a way as to prevent it from acting freely. In the era of diagnosis-related groups (DRGs) and tighter budgets, resulting from past and ongoing health finance reforms, the issue is one that industry needs to keep an eye on, feels Spectaris. The association's Harald Hartmann (firstname.lastname@example.org) is currently assessing the extent of the problem.
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.